PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $128 | -99.7% | 30,416 | +68.6% | 0.00% | +100.0% |
| Q2 2022 | $51,000 | -79.0% | 18,035 | -77.5% | 0.00% | 0.0% |
| Q4 2021 | $243,000 | -65.3% | 80,077 | -20.0% | 0.00% | -75.0% |
| Q3 2021 | $701,000 | -15.2% | 100,111 | +11.1% | 0.00% | -50.0% |
| Q2 2021 | $827,000 | +114.2% | 90,116 | +126.4% | 0.01% | +100.0% |
| Q1 2021 | $386,000 | +6.0% | 39,799 | +12.0% | 0.00% | -42.9% |
| Q4 2020 | $364,000 | -28.1% | 35,536 | -29.2% | 0.01% | -53.3% |
| Q3 2020 | $506,000 | – | 50,188 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |